Position in NAMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$19,514,703
+$1,724,797 QoQ
Shares Held
575,825
+3.6% QoQ
Ownership
0.482%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 197 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. NAMS ranks #100 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in NAMS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,514,703 | 575,825 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $17,789,906 | 555,761 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,690,724 | 532,803 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $42,588,297 | 1,497,479 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $11,548,870 | 637,707 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $8,956,418 | 437,539 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,053,618 | 430,102 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $3,373,201 | 203,205 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $474,330 | 24,692 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $4,199,955 | 177,588 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $318,769 | 28,538 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $15,743 | 1,702 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $9,606 | 808 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,669 | 503 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||